Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Daryl Tan-Yeung Lau, M.D.

Title
Institution
Department
Address
Phone
Fax

Research
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. U19AI088778 (GALE, MICHAEL J) Apr 1, 2010 - Mar 31, 2015
    NIH/NIAID
    Center for the Study of Innate Immunity to HCV Infection
    Role: Co-Principal Investigator
  2. U01DK082919 (LAU, DARYL T) Sep 30, 2008 - May 31, 2021
    NIH
    Harvard Hepatitis B Consortium
    Role: Co-Principal Investigator
  3. R01DK068598 (LAU, DARYL T) Sep 20, 2005 - Aug 31, 2011
    NIH
    Racial Differences in IFN Transcriptional Response
    Role: Principal Investigator
  4. M01RR000073 (ANDERSON, GARLAND D) Dec 1, 1978 - Mar 31, 2010
    NIH/NCRR
    General Clinical Research Center
    Role: Co-Principal Investigator
  5. M01RR001032 (SUKHATME, VIKAS P) Dec 1, 1977 - Mar 31, 2010
    NIH
    General Clinical Research Center
    Role: Co-Principal Investigator

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Kaur SP, Talat A, Karimi-Sari H, Grees A, Chen HW, Lau DTY, Catana AM. Hepatocellular Carcinoma in Hepatitis B Virus-Infected Patients and the Role of Hepatitis B Surface Antigen (HBsAg). J Clin Med. 2022 Feb 21; 11(4). PMID: 35207397.
    Citations:    
  2. Danishwar M, Jamil Z, Khan S, Nakhla M, Ahmad I, Ali MA, Lau DTY. Persistence of Cryoglobulinemic Vasculitis after DAA Induced HCV Cure. J Clin Med. 2022 Feb 14; 11(4). PMID: 35207257.
    Citations:    
  3. Terrault NA, Wahed AS, Feld JJ, Cooper SL, Ghany MG, Lisker-Melman M, Perrillo R, Sterling RK, Khalili M, Chung RT, Rosenthal P, Fontana RJ, Sarowar A, Lau DTY, Wang J, Lok AS, Janssen HLA. Incidence and prediction of HBsAg seroclearance in a prospective multi-ethnic HBeAg-negative chronic hepatitis B cohort. Hepatology. 2022 03; 75(3):709-723. PMID: 34743343.
    Citations: 1     Fields:    Translation:HumansCells
  4. Hanif H, Ali MJ, Susheela AT, Khan IW, Luna-Cuadros MA, Khan MM, Lau DT. Update on the applications and limitations of alpha-fetoprotein for hepatocellular carcinoma. World J Gastroenterol. 2022 Jan 14; 28(2):216-229. PMID: 35110946.
    Citations:    Fields:    Translation:Humans
  5. Luna-Cuadros MA, Chen HW, Hanif H, Ali MJ, Khan MM, Lau DT. Risk of hepatocellular carcinoma after hepatitis C virus cure. World J Gastroenterol. 2022 Jan 07; 28(1):96-107. PMID: 35125821.
    Citations:    Fields:    Translation:HumansCells
  6. Ghany MG, King WC, Lisker-Melman M, Lok ASF, Terrault N, Janssen HLA, Khalili M, Chung RT, Lee WM, Lau DTY, Cloherty GA, Sterling RK. Reply. Hepatology. 2022 03; 75(3):761-763. PMID: 34800047.
    Citations:    Fields:    
  7. Khan IW, Dad Ullah MU, Choudhry M, Ali MJ, Ali MA, Lam SLK, Shah PA, Kaur SP, Lau DTY. Novel Therapies of Hepatitis B and D. Microorganisms. 2021 Dec 17; 9(12). PMID: 34946209.
    Citations:    
  8. Codispodo G, Brown RS, Hans A, Roccaro G, Kostallari E, Schwartz RE, Bamidele AO, Schwartz RE, Buckholz A, Brown RS, Choi AJ, Brown RS, Povero D, Schwartz RE, Jalan-Sakrikar N, Schwartz RE, Sairam NK, Bhan C, Lau DTY, Zhang W, Brown RS. Hepatology Highlights. Hepatology. 2021 12; 74(6):2931-2934. PMID: 34850976.
    Citations:    Fields:    
  9. Kaplan A, Brown RS, Buckholz A, Hang TP, Reshamwala PA, Maiers JL, Schwartz RE, Zhang W, Khanal S, Kostallari E, Bamidele AO, Lee A, Kostallari E, Ullah MUD, Lau DTY, Povero D, Wahid N, Rosenblatt R. Hepatology Highlights. Hepatology. 2021 11; 74(5):2329-2332. PMID: 34672388.
    Citations:    Fields:    
  10. Allamneni C, Vora RS, Bamidele AO, Schwartz RE, Povero D, Salerno DM, Brown RS, Yu RL, Ullah MUD, Lau DTY, Zhang W, Lee A, Kostallari E, Jalan-Sakrikar N, Khanal S, Kostallari E. Hepatology Highlights. Hepatology. 2021 10; 74(4):1727-1729. PMID: 34559905.
    Citations:    Fields:    
  11. Ghany MG, King WC, Lisker-Melman M, Lok ASF, Terrault N, Janssen HLA, Khalili M, Chung RT, Lee WM, Lau DTY, Cloherty GA, Sterling RK. Comparison of HBV RNA and Hepatitis B Core Related Antigen With Conventional HBV Markers Among Untreated Adults With Chronic Hepatitis B in North America. Hepatology. 2021 11; 74(5):2395-2409. PMID: 34133774.
    Citations: 1     Fields:    Translation:HumansCellsCTClinical Trials
  12. Khan IW, Ali MA, Lau DTY, Hang TP, Reshamwala PA, Jalan-Sakrikar N, Schwartz RE, Khanal S, Kostallari E, Choi AJ, Brown RS, Bamidele AO, Povero D, Zhang W, Kaplan A, Louissaint J, Wahid N, Maiers JL. Hepatology Highlights. Hepatology. 2021 09; 74(3):1137-1140. PMID: 34524707.
    Citations:    Fields:    
  13. Wahid N, Jesudian A, Buckholz A, Brown RS, Kovac D, Lee A, Kostallari E, Schwartz RE, Hirsova P, Jalan-Sakrikar N, Hans A, Roccaro G, Kaplan A, Trivedi H, Choudhry M, Lau DTY, Choi AJ. Hepatology Highlights. Hepatology. 2021 08; 74(2):539-542. PMID: 34435695.
    Citations:    Fields:    
  14. Martin P, Nguyen MH, Dieterich DT, Lau DT, Janssen HLA, Peters MG, Jacobson IM. Treatment Algorithm for Managing Chronic Hepatitis B Virus Infection in the United States: 2021 Update. Clin Gastroenterol Hepatol. 2021 Jul 27. PMID: 34329775.
    Citations:    Fields:    
  15. Buckholz A, Lucero C, Yang LM, Lau DTY, Taborda C, Wedd J, Kostallari E, Schwartz RE, Bamidele AO, Sehrawat TS, Kaplan A, Fortune BE, Wahid N, Fortune BE, Choi AJ, Brown RS, Hirsova P, Jalan-Sakrikar N. Hepatology Highlights. Hepatology. 2021 07; 74(1):1-4. PMID: 34302299.
    Citations:    Fields:    
  16. Muhammad Khan M, Alejandra Luna-Cuadros M, Lau DTY, Sehrawat TS, Sehrawat O, Schwartz RE, Choi AJ, Brown RS, Parthasarathy G, Kostallari E, Jalan-Sakrikar N, Salerno DM, Allamneni C, Vora RS, Maiers JL. Hepatology Highlights. Hepatology. 2021 06; 73(6):2085-2088. PMID: 34145622.
    Citations:    Fields:    
  17. Anderson M, Gersch J, Luk KC, Dawson G, Carey I, Agarwal K, Shah P, Dusheiko G, Lau D, Cloherty G. Circulating Pregenomic Hepatitis B Virus RNA Is Primarily Full-length in Chronic Hepatitis B Patients Undergoing Nucleos(t)ide Analogue Therapy. Clin Infect Dis. 2021 06 01; 72(11):2029-2031. PMID: 32687164.
    Citations: 3     Fields:    Translation:HumansCells
  18. Lok AS, Perrillo R, Lalama CM, Fried MW, Belle SH, Ghany MG, Khalili M, Fontana RJ, Sterling RK, Terrault N, Feld JJ, Di Bisceglie AM, Lau DTY, Hassan M, Janssen HLA. Low Incidence of Adverse Outcomes in Adults With Chronic Hepatitis B Virus Infection in the Era of Antiviral Therapy. Hepatology. 2021 06; 73(6):2124-2140. PMID: 32936969.
    Citations: 5     Fields:    Translation:Humans
  19. Buckholz A, Jesudian A, Sehrawat TS, Sehrawat O, Schwartz RE, Muhammad Khan M, Luna-Cuadros MA, Lau DTY, Bamidele AO, Choi AJ, Fortune BE, Hirsova P, Kostallari E, Hang TP, Reshamwala PA, Wahid NA, Rosenblatt R, Jalan-Sakrikar N. Hepatology Highlights. Hepatology. 2021 05; 73(5):1627-1630. PMID: 33914363.
    Citations:    Fields:    
  20. Lau DTY, Ganova-Raeva L, Wang J, Mogul D, Chung RT, Lisker-Melman M, Chang KM, Shaikh OS, Janssen HLA, Wahed AS, Lok AS. Precore and Basal Core Promoter Hepatitis B Virus (HBV) Variants Are Present From a Young Age and Differ Across HBV Genotypes. Hepatology. 2021 05; 73(5):1637-1651. PMID: 32860463.
    Citations: 3     Fields:    Translation:HumansCells
  21. Kaur SP, Trivedi H, Lau DTY, Bamidele AO, Schwartz RE, Parthasarathy G, Navarro-Corcuera A, Sehrawat TS, Hans A, Roccaro G, Jalan-Sakrikar N, Hejazifar N, Brown RS. Hepatology Highlights. Hepatology. 2021 04; 73(4):1245-1247. PMID: 33851455.
    Citations:    Fields:    
  22. Hanif H, Ali MJ, Chen HW, Lau DTY, Parthasarathy G, Schwartz RE, Bamidele AO, Wahid NA, Rosenblatt R, Salerno DM, Brown RS, Buckholz A, Taborda C, Wedd J, Kaplan A, Fortune BE, Jalan-Sakrikar N. Hepatology Highlights. Hepatology. 2021 03; 73(3):877-880. PMID: 33728693.
    Citations:    Fields:    
  23. Buckholz A, Brown RS, Parthasarathy G, Schwartz RE, Allamneni C, Vora RS, Bamidele AO, Salerno DM, Chen HW, Yang L, Lau DTY, Maiers JL, Jalan-Sakrikar N, Wahid NA, Rosenblatt R. Hepatology Highlights. Hepatology. 2021 02; 73(2):475-478. PMID: 33586814.
    Citations:    Fields:    
  24. Satiya J, Kaur SP, Lau DTY, Hejazifar N, Brown RS, Maiers JL, Schwartz RE, Bamidele AO, Kaplan A, Hang TP, Parthasarathy G, Reshamwala PA, Jalan-Sakrikar N, Kostallari E. Hepatology Highlights. Hepatology. 2021 01; 73(1):1-3. PMID: 33616975.
    Citations:    Fields:    
  25. Lu F, Shah PA, Rao A, Gifford-Hollingsworth C, Chen A, Trey G, Soryal M, Talat A, Aslam A, Nasir B, Choudhry S, Ishtiaq R, Sanoff H, Conteh LF, Noonan A, Hu KQ, Schmidt C, Fu M, Civan J, Xiao G, Lau DT, Lu X. Liver Cancer-Specific Serine Protease Inhibitor Kazal Is a Potentially Novel Biomarker for the Early Detection of Hepatocellular Carcinoma. Clin Transl Gastroenterol. 2020 12; 11(12):e00271. PMID: 33512798.
    Citations: 2     Fields:    Translation:Humans
  26. Buckholz A, Brown RS, Trivedi H, Khan MM, Hanif H, Lau DTY, Hans A, Roccaro G, Pisa JF, Jalan-Sakrikar N, Schwartz RE, Russo NW, Sehrawat TS, Kostallari E, Bamidele AO, Parthasarathy G. Hepatology Highlights. Hepatology. 2020 12; 72(6):1893-1896. PMID: 33617006.
    Citations:    Fields:    
  27. Russo NW, Brown RS, Parthasarathy G, Schwartz RE, Buckholz A, Jesudian AB, Kostallari E, Taborda C, Wedd J, Sehrawat TS, Hejazifar N, Yang LM, Lau DTY, Maiers J, Jalan-Sakrikar N. Hepatology Highlights. Hepatology. 2020 11; 72(5):1505-1508. PMID: 33159409.
    Citations:    Fields:    
  28. Hanif H, Khan MM, Ali MJ, Shah PA, Satiya J, Lau DTY, Aslam A. A New Endemic of Concomitant Nonalcoholic Fatty Liver Disease and Chronic Hepatitis B. Microorganisms. 2020 Oct 04; 8(10). PMID: 33020450.
    Citations: 2     
  29. Shah PA, Onken A, Ishtiaq R, Maqsood MH, Patel SS, Campoverde Reyes KJ, Herskovits AZ, Lau DTY. A challenging case of alpha-fetoprotein-result discrepancies in a patient with chronic hepatitis B. Gastroenterol Rep (Oxf). 2020 Dec; 8(6):484-486. PMID: 33447392.
    Citations: 1     
  30. Talat A, Shah PA, Lau DTY, Russo NW, Brown RS, Amir M, Reshamwala P, Fortune B, Jalan-Sakrikar N, Schwartz RE. Hepatology Highlights. Hepatology. 2020 08; 72(2):369-370. PMID: 32841401.
    Citations:    Fields:    
  31. Maqsood MH, Kolli H, Kaur SP, Campoverde Reyes KJ, Guevara J, Shah PA, Talat A, Lau DTY. Improved hepatitis A and hepatitis B vaccination strategy is necessary for patients with chronic hepatitis C. Gastroenterol Rep (Oxf). 2020 Aug; 8(4):326-328. PMID: 32843981.
    Citations:    
  32. Pisa JF, Brown RS, Hirsova P, Schwartz RE, Sehrawat TS, Russo NW, Kostallari E, Tafesh ZH, Fortune B, Trivedi HD, Lau DTY, Morales-Santiago A, Wedd J, Buchl SC, Maiers JL. Hepatology Highlights. Hepatology. 2020 05; 71(5):1527-1529. PMID: 32347990.
    Citations:    Fields:    
  33. Lapumnuaypol K, Danford CJ, Lau DTY, Pisa JF, Brown RS, Morales Santiago A, Roccaro G, Navarro-Corcuera A, Schwartz RE, Kostallari E, Russo NW, Hirsova P, Maiers JL, Jalan-Sakrikar N. Hepatology Highlights. Hepatology. 2020 04; 71(4):1143-1145. PMID: 32276302.
    Citations:    Fields:    
  34. Shah PA, Kaur S, Simons B, Talat A, McMahon B, Lau DTY. Patterns of HBeAg and HBsAg clearance among a treatment-naive Alaskan Cohort in a long-term observational study. J Viral Hepat. 2020 06; 27(6):644-646. PMID: 32043714.
    Citations:    Fields:    Translation:HumansCells
  35. Kaplan A, Rosenblatt R, Russo NW, Brown RS, Pisa JF, Hirsova P, Schwartz RE, Kostallari E, Jalan-Sakrikar N, Idriss R, Trivedi H, Lau DTY, Navarro-Corcuera A. Hepatology Highlights. Hepatology. 2020 02; 71(2):405-407. PMID: 32037633.
    Citations:    Fields:    
  36. Shah PA, Lau DTY, Russo NW, Brown RS, Maiers JL, Schwartz RE, Imai N, Krisko TI, Navarro-Corcuera A, Jalan-Sakrikar N, Pisa JF, Jesudian AB, Tafesh ZH, Fortune BE, Kostallari E. Hepatology Highlights. Hepatology. 2020 01; 71(1):1-3. PMID: 31961974.
    Citations:    Fields:    
  37. Pisa JF, Brown RS, Yang LM, Lau DTY, Fortune BE, Aseem SO, Schwartz RE, Russo N, Gupta V, Amir M, Roccaro G, Jalan-Sakrikar N, Kostallari E, Navarro-Corcuera A. Hepatology Highlights. Hepatology. 2019 Dec; 70(6):1881-1884. PMID: 31785048.
    Citations:    Fields:    
  38. Amir M, Vora RS, Tafesh ZH, Jesudian A, Gupta V, Schwartz RE, Russo N, Danford CJ, Lau DTY, Brown RS, Jalan-Sakrikar N, Maiers JL, Sharma R, Fortune BE, Hilscher M, Aseem SO. Hepatology Highlights. Hepatology. 2019 11; 70(5):1497-1499. PMID: 31661168.
    Citations:    Fields:    
  39. Zhou K, Wahed AS, Cooper S, Di Bisceglie AM, Fontana RJ, Ghany MG, Khalili M, Lok AS, Perrillo R, Lee WM, Lau DTY, Sterling R, Janssen HLA, Terrault NA. Phase Transition Is Infrequent Among North American Adults With e-Antigen-Negative Chronic Hepatitis B and Low-Level Viremia. Am J Gastroenterol. 2019 11; 114(11):1753-1763. PMID: 31658127.
    Citations: 2     Fields:    Translation:HumansCells
  40. Shah PA, Choudhry S, Reyes KJC, Lau DTY. An update on the management of chronic hepatitis D. Gastroenterol Rep (Oxf). 2019 Dec; 7(6):396-402. PMID: 32494363.
    Citations: 1     
  41. Hirsova P, Malhi H, Russo N, Shah PA, Trivedi H, Lau DTY, Pisa JF, Wu A, Shen N, Jesudian A, Tafesh ZH, Fortune BE, Hilscher M, Jalan-Sakrikar N, Mousa O. Hepatology Highlights. Hepatology. 2019 Aug; 70(2):455-458. PMID: 31376309.
    Citations:    Fields:    
  42. Mousa OY, Malhi H, Russo N, Jesudian A, Pisa JF, Kulai TB, Maiers JL, Kostallari E, Jalan-Sakrikar N, Tafesh ZH, Fortune BE, Yang L, Lau DTY, Nair K, Wedd J. Hepatology Highlights. Hepatology. 2019 07; 70(1):1-4. PMID: 31245883.
    Citations:    Fields:    
  43. Suri JS, Ezaz G, Lau DTY, Kulai TB, Malhi H, Tafesh ZH, Fortune B, Rosenblatt R, Brown RS, Pisa JF, Russo N, Hirsova P, Schwartz RE, Obaidullah Aseem S, Jalan-Sakrikar N, Gupta V. Hepatology Highlights. Hepatology. 2019 Jun; 69(6):2311-2314. PMID: 31141204.
    Citations: 1     Fields:    
  44. Di Bisceglie AM, King WC, Lisker-Melman M, Khalili M, Belle SH, Feld JJ, Ghany MG, Janssen HLA, Lau D, Lee WM, Ling SC, Cooper S, Rosenthal P, Schwarz KB, Sterling RK, Teckman JH, Terrault N. Age, race and viral genotype are associated with the prevalence of hepatitis B e antigen in children and adults with chronic hepatitis B. J Viral Hepat. 2019 07; 26(7):856-865. PMID: 30974509.
    Citations: 4     Fields:    Translation:HumansCellsPHPublic Health
  45. Trivedi HD, Lau DTY, Kulai TB, Malhi H, Schwartz RE, Pisa JF, Brown RS, Russo N, Nair KM, Roccaro G, Hirsova P, Gupta V, Xu X, Krisko T, Kostallari E. Hepatology Highlights. Hepatology. 2019 05; 69(5):1849-1851. PMID: 30977535.
    Citations:    Fields:    
  46. Chang KM, Traum D, Park JJ, Ho S, Ojiro K, Wong DK, Wahed AS, Terrault NA, Khalili M, Sterling RK, Janssen HLA, Shuhart MC, Lau DT, Roberts LR, Johnson GS, Kaplan DE, Betts MR, Lee WM, Lok ASF. Distinct phenotype and function of circulating Vd1+ and Vd2+ ?dT-cells in acute and chronic hepatitis B. PLoS Pathog. 2019 04; 15(4):e1007715. PMID: 30998783.
    Citations: 13     Fields:    Translation:HumansCells
  47. Nair KM, Vora RS, Mousa OY, Malhi H, Schwartz RE, Pisa JF, Brown RS, Trivedi HD, Lau DTY, Shen N, Shenoy A, Maiers JL, Kostallari E, Hirsova P, Russo N, Kulai TB. Hepatology Highlights. Hepatology. 2019 04; 69(4):1365-1368. PMID: 30920689.
    Citations:    Fields:    
  48. Mousa O, Malhi H, Schwartz RE, Kulai TB, Trivedi HD, Lau DTY, Shen NT, Brown RS, Hirsova P, Xu X, Nicholls HT, Pisa JF, Tafesh ZH, Fortune BE, Gupta V, Kostallari E, Russo N, Jesudian AB. Hepatology Highlights. Hepatology. 2019 03; 69(3):927-930. PMID: 30811657.
    Citations:    Fields:    
  49. Ishida Y, Kakuni M, Bang BR, Sugahara G, Lau DT, Tateno-Mukaidani C, Li M, Gale M, Saito T. Hepatic IFN-Induced Protein with Tetratricopeptide Repeats Regulation of HCV Infection. J Interferon Cytokine Res. 2019 03; 39(3):133-146. PMID: 30844328.
    Citations: 1     Fields:    Translation:HumansCells
  50. Aslam A, Ishtiaq R, Lau DTY. Timely Administration of Birth Dose Hepatitis B Virus Vaccine May Break the Chain of Perinatal Transmission. Hepatology. 2019 05; 69(5):2284-2286. PMID: 30372542.
    Citations:    Fields:    Translation:HumansCellsPHPublic Health
  51. Brouwer WP, Zhao Q, Hansen BE, Lau D, Khalili M, Terrault NA, Di Bisceglie AM, Perrillo RP, Fried MW, Wong D, Feld JJ, Belle SH, Janssen HLA. HBV Genotype-Specific Levels of Hepatitis B Surface Antigen Improve HBV Phenotype Definition. Clin Gastroenterol Hepatol. 2020 01; 18(1):259-261. PMID: 30630104.
    Citations: 1     Fields:    Translation:HumansCells
  52. Mehta AS, Lau DT, Wang M, Aslam A, Nasir B, Javaid A, Poongkunran M, Block TM. Correction: Application of the Doylestown algorithm for the early detection of hepatocellular carcinoma. PLoS One. 2018; 13(10):e0206835. PMID: 30372488.
    Citations: 1     Fields:    
  53. Ajmera V, Huang H, Dao D, Feld JJ, Lau DT, Patel K, Rule JA, Daly M, Lee WM, Chung RT. Host Genetic Variant in CXCL16 May Be Associated With Hepatitis B Virus-Related Acute Liver Failure. Cell Mol Gastroenterol Hepatol. 2019; 7(2):477-479.e4. PMID: 30827414.
    Citations: 1     Fields:    Translation:HumansCells
  54. Mehta AS, Lau DT, Wang M, Aslam A, Nasir B, Javaid A, Poongkunran M, Block TM. Application of the Doylestown algorithm for the early detection of hepatocellular carcinoma. PLoS One. 2018; 13(8):e0203149. PMID: 30169533.
    Citations: 3     Fields:    Translation:Humans
  55. Aslam A, Campoverde Reyes KJ, Malladi VR, Ishtiaq R, Lau DTY. Management of chronic hepatitis B during pregnancy. Gastroenterol Rep (Oxf). 2018 Nov; 6(4):257-262. PMID: 30430013.
    Citations: 6     
  56. Aslam A, Susheela A, Iriana S, Chan SS, Lau D. Acute hepatitis E superinfection leading to chronic hepatitis B reactivation. BMJ Case Rep. 2018 Jun 10; 2018. PMID: 29891510.
    Citations: 2     Fields:    Translation:HumansCells
  57. Yuen MF, Chen DS, Dusheiko GM, Janssen HLA, Lau DTY, Locarnini SA, Peters MG, Lai CL. Hepatitis B virus infection. Nat Rev Dis Primers. 2018 06 07; 4:18035. PMID: 29877316.
    Citations: 137     Fields:    Translation:HumansCellsPHPublic Health
  58. Chang CY, Aziz N, Poongkunran M, Javaid A, Trinh HN, Lau DT, Nguyen MH. Serum Aminotransferase Flares in Pregnant and Postpartum Women With Current or Prior Treatment for Chronic Hepatitis B. J Clin Gastroenterol. 2018 03; 52(3):255-261. PMID: 28323748.
    Citations: 14     Fields:    Translation:HumansCells
  59. Chang CY, Aziz N, Poongkunran M, Javaid A, Trinh HN, Lau D, Nguyen MH. Serum Alanine Aminotransferase and Hepatitis B DNA Flares in Pregnant and Postpartum Women with Chronic Hepatitis B. Am J Gastroenterol. 2016 10; 111(10):1410-1415. PMID: 27456990.
    Citations: 24     Fields:    Translation:HumansCells
  60. Ahn J, Lim JK, Lee HM, Lok AS, Nguyen M, Pan CQ, Mannalithara A, Te H, Reddy KR, Trinh H, Chu D, Tran T, Lau D, Leduc TS, Min A, Trong Le L, Bae H, Van Tran S, Do S, Hann HW, Wong C, Han S, Pillai A, Park JS, Tong M, Scaglione S, Woog J, Kim WR. Lower Observed Hepatocellular Carcinoma Incidence in Chronic Hepatitis B Patients Treated With Entecavir: Results of the ENUMERATE Study. Am J Gastroenterol. 2016 09; 111(9):1297-304. PMID: 27325221.
    Citations: 11     Fields:    Translation:Humans
  61. Safaie P, Poongkunran M, Kuang PP, Javaid A, Jacobs C, Pohlmann R, Nasser I, Lau DT. Intrahepatic distribution of hepatitis B virus antigens in patients with and without hepatocellular carcinoma. World J Gastroenterol. 2016 Mar 28; 22(12):3404-11. PMID: 27022222.
    Citations: 4     Fields:    Translation:HumansCells
  62. Javaid A, Poongkunran M, Allard FD, Kyaw W, Maung HH, Lau D. Subtle presentation of active primary biliary cirrhosis in chronic hepatitis B: a case report. Gastroenterol Rep (Oxf). 2017 05; 5(2):157-160. PMID: 26893441.
    Citations: 1     
  63. Park JJ, Wong DK, Wahed AS, Lee WM, Feld JJ, Terrault N, Khalili M, Sterling RK, Kowdley KV, Bzowej N, Lau DT, Kim WR, Smith C, Carithers RL, Torrey KW, Keith JW, Levine DL, Traum D, Ho S, Valiga ME, Johnson GS, Doo E, Lok AS, Chang KM. Hepatitis B Virus--Specific and Global T-Cell Dysfunction in Chronic Hepatitis B. Gastroenterology. 2016 Mar; 150(3):684-695.e5. PMID: 26684441.
    Citations: 74     Fields:    Translation:HumansCells
  64. Kim WR, Berg T, Asselah T, Flisiak R, Fung S, Gordon SC, Janssen HL, Lampertico P, Lau D, Bornstein JD, Schall RE, Dinh P, Yee LJ, Martins EB, Lim SG, Loomba R, Petersen J, Buti M, Marcellin P. Evaluation of APRI and FIB-4 scoring systems for non-invasive assessment of hepatic fibrosis in chronic hepatitis B patients. J Hepatol. 2016 Apr; 64(4):773-80. PMID: 26626497.
    Citations: 81     Fields:    Translation:Humans
  65. Lake-Bakaar GV, Lau D, Kuang PP, Singh K. Controlled Therapy Interruption Improves Host Immune Control of Chronic Hepatitis B Virus Infection in HBeAg-Positive Patients. Viral Immunol. 2015 Dec; 28(10):564-9. PMID: 26501982.
    Citations:    Fields:    Translation:Humans
  66. Khalili M, Lombardero M, Chung RT, Terrault NA, Ghany MG, Kim WR, Lau D, Lisker-Melman M, Sanyal A, Lok AS. Diabetes and prediabetes in patients with hepatitis B residing in North America. Hepatology. 2015 Nov; 62(5):1364-74. PMID: 26390278.
    Citations: 13     Fields:    Translation:Humans
  67. Inci F, Filippini C, Baday M, Ozen MO, Calamak S, Durmus NG, Wang S, Hanhauser E, Hobbs KS, Juillard F, Kuang PP, Vetter ML, Carocci M, Yamamoto HS, Takagi Y, Yildiz UH, Akin D, Wesemann DR, Singhal A, Yang PL, Nibert ML, Fichorova RN, Lau DT, Henrich TJ, Kaye KM, Schachter SC, Kuritzkes DR, Steinmetz LM, Gambhir SS, Davis RW, Demirci U. Multitarget, quantitative nanoplasmonic electrical field-enhanced resonating device (NE2RD) for diagnostics. Proc Natl Acad Sci U S A. 2015 Aug 11; 112(32):E4354-63. PMID: 26195743.
    Citations: 20     Fields:    Translation:HumansCells
  68. Martin P, Lau DT, Nguyen MH, Janssen HL, Dieterich DT, Peters MG, Jacobson IM. A Treatment Algorithm for the Management of Chronic Hepatitis B Virus Infection in the United States: 2015 Update. Clin Gastroenterol Hepatol. 2015 Nov; 13(12):2071-87.e16. PMID: 26188135.
    Citations: 33     Fields:    Translation:HumansCells
  69. Yildiz UH, Inci F, Wang S, Toy M, Tekin HC, Javaid A, Lau DT, Demirci U. Recent advances in micro/nanotechnologies for global control of hepatitis B infection. Biotechnol Adv. 2015 Jan-Feb; 33(1):178-190. PMID: 25450190.
    Citations: 14     Fields:    Translation:HumansCellsPHPublic Health
  70. Ghany MG, Perrillo R, Li R, Belle SH, Janssen HL, Terrault NA, Shuhart MC, Lau DT, Kim WR, Fried MW, Sterling RK, Di Bisceglie AM, Han SH, Ganova-Raeva LM, Chang KM, Lok AS. Characteristics of adults in the hepatitis B research network in North America reflect their country of origin and hepatitis B virus genotype. Clin Gastroenterol Hepatol. 2015 Jan; 13(1):183-92. PMID: 25010003.
    Citations: 50     Fields:    Translation:HumansCells
  71. Tapper EB, Krajewski K, Lai M, Challies T, Kane R, Afdhal N, Lau D. Simple non-invasive biomarkers of advanced fibrosis in the evaluation of non-alcoholic fatty liver disease. Gastroenterol Rep (Oxf). 2014 Nov; 2(4):276-80. PMID: 25002154.
    Citations: 22     
  72. Dill MT, Makowska Z, Trincucci G, Gruber AJ, Vogt JE, Filipowicz M, Calabrese D, Krol I, Lau DT, Terracciano L, van Nimwegen E, Roth V, Heim MH. Pegylated IFN-a regulates hepatic gene expression through transient Jak/STAT activation. J Clin Invest. 2014 Apr; 124(4):1568-81. PMID: 24569457.
    Citations: 21     Fields:    Translation:HumansCells
  73. Safaie P, Ham M, Kuang P, Mehta AS, Wang M, Cheifetz AS, Robson S, Lau D, Block TM, Moss AC. Lectin-reactive anti-a-gal in patients with Crohn's disease: correlation with clinical phenotypes. Inflamm Bowel Dis. 2013 Dec; 19(13):2796-800. PMID: 24185312.
    Citations: 1     Fields:    Translation:Humans
  74. McMahon BJ, Bulkow L, Simons B, Zhang Y, Negus S, Homan C, Spradling P, Teshale E, Lau D, Snowball M, Livingston SE. Relationship between level of hepatitis B virus DNA and liver disease: a population-based study of hepatitis B e antigen-negative persons with hepatitis B. Clin Gastroenterol Hepatol. 2014 Apr; 12(4):701-6.e1-3. PMID: 24035774.
    Citations: 9     Fields:    Translation:HumansCells
  75. Negash AA, Ramos HJ, Crochet N, Lau DT, Doehle B, Papic N, Delker DA, Jo J, Bertoletti A, Hagedorn CH, Gale M. IL-1ß production through the NLRP3 inflammasome by hepatic macrophages links hepatitis C virus infection with liver inflammation and disease. PLoS Pathog. 2013; 9(4):e1003330. PMID: 23633957.
    Citations: 199     Fields:    Translation:HumansCells
  76. Wilkins C, Woodward J, Lau DT, Barnes A, Joyce M, McFarlane N, McKeating JA, Tyrrell DL, Gale M. IFITM1 is a tight junction protein that inhibits hepatitis C virus entry. Hepatology. 2013 Feb; 57(2):461-9. PMID: 22996292.
    Citations: 95     Fields:    Translation:HumansCells
  77. Lau DT, Negash A, Chen J, Crochet N, Sinha M, Zhang Y, Guedj J, Holder S, Saito T, Lemon SM, Luxon BA, Perelson AS, Gale M. Innate immune tolerance and the role of kupffer cells in differential responses to interferon therapy among patients with HCV genotype 1 infection. Gastroenterology. 2013 Feb; 144(2):402-413.e12. PMID: 23123437.
    Citations: 36     Fields:    Translation:HumansCells
  78. Tapper EB, Lau DT. The need for clarity in occult HBV infection. J Viral Hepat. 2011 Oct; 18(10):673-4. PMID: 21914083.
    Citations: 1     Fields:    Translation:HumansCells
  79. Skums P, Campo DS, Dimitrova Z, Vaughan G, Lau DT, Khudyakov Y. Numerical detection, measuring and analysis of differential interferon resistance for individual HCV intra-host variants and its influence on the therapy response. In Silico Biol. 2011-2012; 11(5-6):263-9. PMID: 23202427.
    Citations: 5     Fields:    Translation:HumansCells
  80. Jamma S, Hussain G, Lau DT. Current Concepts of HBV/HCV Coinfection: Coexistence, but Not Necessarily in Harmony. Curr Hepat Rep. 2010; 9(4):260-269. PMID: 21258658.
    Citations: 16     
  81. Liang Y, Shilagard T, Xiao SY, Snyder N, Lau D, Cicalese L, Weiss H, Vargas G, Lemon SM. Visualizing hepatitis C virus infections in human liver by two-photon microscopy. Gastroenterology. 2009 Oct; 137(4):1448-58. PMID: 19632233.
    Citations: 95     Fields:    Translation:HumansCells
  82. Lau DT, Bleibel W. Current status of antiviral therapy for hepatitis B. Therap Adv Gastroenterol. 2008 Jul; 1(1):61-75. PMID: 21180515.
    Citations: 6     
  83. Lau DT, Fish PM, Sinha M, Owen DM, Lemon SM, Gale M. Interferon regulatory factor-3 activation, hepatic interferon-stimulated gene expression, and immune cell infiltration in hepatitis C virus patients. Hepatology. 2008 Mar; 47(3):799-809. PMID: 18203148.
    Citations: 55     Fields:    Translation:HumansCells
  84. Pawlotsky JM, Dusheiko G, Hatzakis A, Lau D, Lau G, Liang TJ, Locarnini S, Martin P, Richman DD, Zoulim F. Virologic monitoring of hepatitis B virus therapy in clinical trials and practice: recommendations for a standardized approach. Gastroenterology. 2008 Feb; 134(2):405-15. PMID: 18242209.
    Citations: 72     Fields:    Translation:Humans
  85. Gish RG, Lau DT, Schmid P, Perrillo R. A pilot study of extended duration peginterferon alfa-2a for patients with hepatitis B e antigen-negative chronic hepatitis B. Am J Gastroenterol. 2007 Dec; 102(12):2718-23. PMID: 17662102.
    Citations: 12     Fields:    Translation:Humans
  86. Snyder N, Nguyen A, Gajula L, Soloway R, Xiao SY, Lau DT, Petersen J. The APRI may be enhanced by the use of the FIBROSpect II in the estimation of fibrosis in chronic hepatitis C. Clin Chim Acta. 2007 Jun; 381(2):119-23. PMID: 17442291.
    Citations: 12     Fields:    Translation:Humans
  87. Hollinger FB, Lau DT. Hepatitis B: the pathway to recovery through treatment. Gastroenterol Clin North Am. 2006 Dec; 35(4):895-931. PMID: 17129820.
    Citations: 9     Fields:    Translation:HumansCells
  88. Tripathi RL, Krishnan P, He Y, Middleton T, Pilot-Matias T, Chen CM, Lau DT, Lemon SM, Mo H, Kati W, Molla A. Replication efficiency of chimeric replicon containing NS5A-5B genes derived from HCV-infected patient sera. Antiviral Res. 2007 Jan; 73(1):40-9. PMID: 16914212.
    Citations: 15     Fields:    Translation:HumansCells
  89. Snyder N, Gajula L, Xiao SY, Grady J, Luxon B, Lau DT, Soloway R, Petersen J. APRI: an easy and validated predictor of hepatic fibrosis in chronic hepatitis C. J Clin Gastroenterol. 2006 Jul; 40(6):535-42. PMID: 16825937.
    Citations: 33     Fields:    Translation:HumansCTClinical Trials
  90. Loo YM, Owen DM, Li K, Erickson AK, Johnson CL, Fish PM, Carney DS, Wang T, Ishida H, Yoneyama M, Fujita T, Saito T, Lee WM, Hagedorn CH, Lau DT, Weinman SA, Lemon SM, Gale M. Viral and therapeutic control of IFN-beta promoter stimulator 1 during hepatitis C virus infection. Proc Natl Acad Sci U S A. 2006 Apr 11; 103(15):6001-6. PMID: 16585524.
    Citations: 203     Fields:    Translation:HumansCells
  91. Lau DT, Hewlett AT. Screening for hepatitis A and B antibodies in patients with chronic liver disease. Am J Med. 2005 Oct; 118 Suppl 10A:28S-33S. PMID: 16271538.
    Citations: 7     Fields:    Translation:HumansCells
  92. Helbig KJ, Lau DT, Semendric L, Harley HA, Beard MR. Analysis of ISG expression in chronic hepatitis C identifies viperin as a potential antiviral effector. Hepatology. 2005 Sep; 42(3):702-10. PMID: 16108059.
    Citations: 97     Fields:    Translation:HumansCells
  93. Lau DT, Luxon BA, Xiao SY, Beard MR, Lemon SM. Intrahepatic gene expression profiles and alpha-smooth muscle actin patterns in hepatitis C virus induced fibrosis. Hepatology. 2005 Aug; 42(2):273-81. PMID: 15986378.
    Citations: 25     Fields:    Translation:Humans
  94. Lau DT, Membreno FE. Antiviral therapy for treatment-naïve hepatitis B virus patients. Gastroenterol Clin North Am. 2004 Sep; 33(3):581-99, ix-x. PMID: 15324945.
    Citations: 1     Fields:    Translation:Humans
  95. Wightman F, Walters T, Ayres A, Bowden S, Bartholomeusz A, Lau D, Locarnini S, Lewin SR. Comparison of sequence analysis and a novel discriminatory real-time PCR assay for detection and quantification of Lamivudine-resistant hepatitis B virus strains. J Clin Microbiol. 2004 Aug; 42(8):3809-12. PMID: 15297535.
    Citations: 6     Fields:    Translation:HumansCells
  96. Lau DT, Ma H, Lemon SM, Doo E, Ghany MG, Miskovsky E, Woods GL, Park Y, Hoofnagle JH. A rapid immunochromatographic assay for hepatitis B virus screening. J Viral Hepat. 2003 Jul; 10(4):331-4. PMID: 12823602.
    Citations: 7     Fields:    Translation:HumansCellsPHPublic Health
  97. Soza A, Lau DT, Khokhar MF, Conjeevaram H, Park Y, Hoofnagle JH. Resolution of chronic hepatitis B-associated autoimmune neutropenia with interferon-alpha therapy. J Pediatr Gastroenterol Nutr. 2003 Jan; 36(1):141-3. PMID: 12500011.
    Citations: 1     Fields:    Translation:Humans
  98. Lau DT, Kleiner DE, Ghany MG, Park Y, Schmid P, Hoofnagle JH. 10-Year follow-up after interferon-alpha therapy for chronic hepatitis C. Hepatology. 1998 Oct; 28(4):1121-7. PMID: 9755252.
    Citations: 38     Fields:    Translation:HumansCellsCTClinical Trials
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Lau's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (229)
Explore
_
Co-Authors (20)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.